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Abstract
Natural killer cells are innate effector cells known for their potential to produce interferon-c and kill tumour and virus-
infected cells. Recently, B220
+CD11c
intNK1.1
+ NK cells were found to also have antigen-presenting capacity like dendritic
cells (DC), hence their name interferon-producing killer DC (IKDC). Shortly after discovery, it has already been questioned if
IKDC really represent a separate subset of NK cells or merely represent a state of activation. Despite similarities with DCs, in
vivo evidence that they behave as bona fide APCs is lacking. Here, using a model of influenza infection, we found
recruitment of both conventional B220
2 NK cells and IKDCs to the lung. To study antigen-presenting capacity of NK cell
subsets and compare it to cDCs, all cell subsets were sorted from lungs of infected mice and co-cultured ex vivo with
antigen specific T cells. Both IKDCs and conventional NK cells as well as cDCs presented virus-encoded antigen to CD8 T
cells, whereas only cDCs presented to CD4 T cells. The absence of CD4 responses was predominantly due to a deficiency in
MHCII processing, as preprocessed peptide antigen was presented equally well by cDCs and IKDCs. In vivo, the depletion of
NK1.1-positive NK cells and IKDCs reduced the expansion of viral nucleoprotein-specific CD8 T cells in the lung and spleen,
but did finally not affect viral clearance from the lung. In conclusion, we found evidence for APC function of lung NK cells
during influenza infection, but this is a feature not exclusive to the IKDC subset.
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Introduction
Influenza type A is a cytolytic virus that causes acute respiratory
infection of which the clinical outcome can vary greatly. The way
in which the innate and adaptive immune system initially
recognizes and deals with replicating virus could be decisive in
determining outcome of infection, as this might heavily influence
the kinetics of viral clearance [1,2,3]. In immediate response to
viral infection, innate defence mechanisms consist of high level
production of type I interferons by infected epithelial cells, alveolar
macrophages and natural interferon producing cells, as well as
recruitment of neutrophils and NK cells [4,5,6]. NK cells can kill
virus-infected cells without prior antigen stimulation [7,8,9] in a
process that is controlled by inhibitory and activating receptors, of
which the activating natural killer cell receptor (Ncr1) gene product
is most crucial during influenza infection [9,10,11]. How exactly
this innate immune response influences or enhances initiation of
adaptive immunity is poorly understood.
By expressing a wide array of microbial pattern recognition
receptors shared with cells of the innate immune response and at
the same time displaying the potential to process and present
antigen to naive T cells, lung DCs bridge innate and adaptive
immunity [12]. During influenza infection, both conventional
(cDC) and plasmacytoid (p)DCs exert different functions, but both
are necessary to induce an immune response that clears the virus
from the lungs and prevents re-infection [13]. Recently it has been
proposed that new member in the mouse DC family might display
both innate immune functions of NK cells, as well as the potential
to process and present antigen to naı ¨ve T cells, the so-called
interferon producing killer DC, or IKDC [14,15]. Phenotypically
IKDCs are defined as non-T (CD3
2), non-B (CD19
2) cells, with
expression of intermediate levels of CD11c, B220, and MHC class
II, and high-level expression of NK-specific markers NK1.1 and
NKp46 controlled by the Ncr1-locus [14,15,16]. Functionally,
IKDCs have the capacity to kill NK-sensitive target cells without
prior activation, and induce proliferation of naı ¨ve T cells when
pulsed with antigenic peptides. By contrast, conventional NK cells
that lack expression of B220 and MHCII have not been identified
as antigen presenting cells in the mouse [17]. Although the
existence of the IKDC population would make evolutionary sense,
it has been controversial whether IKDCs really represent a
separate DC lineage or nothing else but activated NK cells,
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supported by the fact that human NK cells have long been known
to have APC-like activity [19,20]. The developmental pathways
between NK cells and IKDCs also overlap as both rely on the IL-
2Rb, IL-5Rb and common c chain (and thus a functional IL-15R
complex) and IL-15 for development, whereas cDCs and pDCs
develop in the absence of a functional IL-15R [15,16].
Furthermore there was some doubt whether resting or CpG
activated splenic IKDCs could present protein antigen or relevant
pathogens (as opposed to pre-processed peptide) to CD8 and CD4
T cells ex vivo [21]. Therefore, some authors suggest that IKDCs
are functionally and developmentally closer to NK cells than to the
two best-known DC family members.
Here, we have studied the antigen presenting capacities of
conventional NK cells, IKDCs and cDCs during influenza
infection. Subsets of conventional NK and IKDCs were sorted
from the lungs of infected mice to study their APC potential, in
direct comparison with conventional DCs. We found clear
evidence for recruitment of NK subsets to lungs of infected mice
and both conventional and IKDC subsets were able to present
virus-encoded antigen to CD8 cells, but not CD4 T cells. In
support, NK1.1 depletion led to a reduced expansion of virus
specific CD8 T cells in the spleen and lung. However, viral
clearance was unaffected. These data support an APC function for
NK cells, which is not unique to the IKDC subset.
Results
Surface phenotype analysis of lung DC subsets and NK
cells following influenza virus infection
There is considerable overlap in the level of expression of
phenotypical markers that have been used to discriminate putative
IKDCs from pDCs, cDCs and NK cells. In an attempt to make a
head to head comparison of these various subsets in lungs in steady
state conditions (mock infected mice) or during influenza infection,
we have employed 10-colour flow cytometry to rigorously define
phenotypes and activation status. We first gated on live cells in the
lung and subsequently gated out the CD19
+ B and CD3
+ T cells
(Figure 1A, left plot), while discriminating between B220
+ and
B220
2 cells. Conventional DCs (cDC) are described as being low
for B220, while expressing high levels of CD11c and MHCII. As
previously described by others, and us, in steady state conditions
(mock) these cells can be further discriminated into a CD11b
+
and a CD11b
2 subpopulation lacking expression of 120G8 as
depicted in the lower panels of Figure 1A [13,22]. The
CD3
2CD19
2B220
2 population also contained the conventional
NK1.1
+ NK cells. When selecting for CD3
2CD19
2B220
+ cells,
we found two populations of CD11c
int cells in steady state
conditions, which can be further discriminated into pDCs by
expression of the pDC marker bone marrow stromal antigen-2
recognized by the moAb 120G8. The 120G8
+CD11c
int population
represents NK1.1
2CD11b
2 pDCs with low forward and side
scatter, whereas the 120G8
2CD11c
int population represents
NK1.1
hiCD11b
int IKDCs, also of small size and scatter [14]. In
influenza X-31 infected lungs, there was a striking difference in the
characteristics of isolated populations found at 4 days post
infection. Firstly, within the B220
2MHCII
hiCD11c
hi cDC, there
was a loss of the CD11b
2 subset, as recently reported, and the
remaining CD11b
hi DCs co-expressed 120G8 (a pDC marker
shown to be induced by interferon production) [23,13]. Even more
strikingly, the B220
+ cells now also contained a subset of cells that
highly expressed CD11c (like cDCs) as well as 120G8 (like pDCs).
Further analysis of this population revealed that it expressed very
high levels of CD11b and intermediate levels of NK1.1, although a
subset of these cells was as high in expression of NK1.1 as IKDCs
and NK cells. These cells were however larger and expressed very
high levels of MHCII, most likely resembling inflammatory DCs,
recently surged from monocytes [24,25]. Figure 1B demonstrates
that the expression of the IL-2-IL-15 receptor b chain (CD122)
was only expressed on NK cells and IKDCs, but not on pDCs or
cDCs, as previously described [15]. In addition, IKDCs in the
lungs expressed NKG2D and PDL1 (also known as B7H-1)(data
not shown).
During influenza infection, both lung IKDCs and B220
2
NK cells lyse NK-sensitive targets
The main function of NK cells is known to be cell lysis without
prior activation in a process requiring granzyme A and B. We
compared expression of these molecules by qPCR on lung derived
NK cell subsets and cDCs, and found higher expression levels of
both Granzym A and B on IKDCs than on regular B220
2 NK
cells. On cDCs no expression was detected (Figure 2A). Next, the
functional capacity to lyse NK-sensitive YAC target cells was
studied by using a CFSE-labeled YAC assay as described
previously [26]. In line with granzyme expression and expression
of activating NK receptors, both IKDCs and B220
2 NK cells
sorted from infected lung tissue efficiently lysed YAC-1 target
cells (Figure 2B), to a degree that is seen when using splenic NK
cells as effector cells, supporting the idea that lung
CD3
2CD19
2B220
+CD11c
intNK1.1
+ cells also functionally be-
have like IKDCs [15,21].
Kinetics and maturation state of IKDCs, B220
2NK cells,
and cDCs in lung following influenza virus infection
As influenza X-31 infection is a mild infection localized in the
respiratory tract, we studied the effect of infection on the number
and maturation status of IKDCs in the respiratory tract (lung,
bronchoalveolar compartment (BALf), mediastinal LN (MLN) and
the spleen), using the multi-parameter gating strategy as above. A
kinetic analysis at various days post infection (dpi) revealed that
IKDCs, B220
2NK cells and cDCs accumulated in the lungs with
different kinetics and to different extents; IKDCs and cDCs
peaking at 7dpi whereas NK cells were increased from day 1 to 7
post infection compared with mock infected mice (data shown for
digested lung tissue). For clarity reasons we lumped CD11b
+ and
CD11b
2 cDCs together, but we have recently provided detail on
this [13]. We next defined the co-stimulatory molecule expression
on these various populations at 4 dpi. Whereas we could find an
increased number of IKDCs in all compartments (Figure 3A
depicts only the digested lung samples), the increase in expression
of the maturation marker CD86 (Figure 3B) and expression of
MHC class II (Figure 3C) molecules was restricted to the site of
primary infection being lung and BALf (figures depict lung tissue)
and occurred on both IKDCs, B220
2NK cells and cDCs, albeit to
different degrees. Notably there were no signs of cDC, NK or
IKDC activation in spleen or MLN (data not shown).
An increase in IKDCs could be due to increased chemoattrac-
tion of IKDCs to the lung, in a process that might be controlled by
CXCR3 and/or CCR2 [27]. We therefore examined expression
levels of the CXCR3 ligands CXCL10 (IP-10), CXCL11 (ITAC),
as well as the CCR2 ligands CCL2 (MCP-1) on a genome-wide
expression micro array performed on whole lung homogenate
from mock-infected or X-31 infected mice at various hours post
infection (hpi) (Figure 3D, full microarray data to be published
elsewhere). Analysis revealed that these chemokines were clearly
upregulated with similar kinetics as gene products associated with
NK and/or IKDC function such as Ncr1, granzyme A and B, klrk1,
IKDC in Influenza
PLoS ONE | www.plosone.org 2 September 2009 | Volume 4 | Issue 9 | e7187Figure 1. Identification of NK and DC subsets cell in lung tissue. (A) 10-color flowcytometric analysis of lung tissue. A CD3/CD19 negative
population was gated from live, low autofluorescent cells in the lung. The B220 high population was further subdivided based on CD11c, 120G8,
CD11b and NK1.1. After influenza virus infection, three populations could be clearly demarkated.CD11c
interm120G8
lowNK1.1
hiIKDCs, CD11c
interm120-
G8
hiNK1.1
loCD11b
lo pDCs and CD11c
hi120G8
hiCD11b
hiMHCII
hi iDCs. The iDC population was completely absent in steady state condition. In the B220
low population cDCs were gated as MHII
hiCD11c
hi and NK cells as a NK1.1
hi population expressing intermediate levels of CD11b. (B) Histograms
demonstrating CD122 expression on NK cells, IKDCs and cDCs. The grey histogram represents isotype control, black histogram represents CD122
expression. Representative of 3 experiments.
doi:10.1371/journal.pone.0007187.g001
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proliferation or survival inside the lung, possibly due to the
presence of homeostatic cytokines of the IL-2 family that share the
cc chain for signaling (IL-2, IL-15, IL-21). Based on array data,
there was induction at 2 dpi in the lung of IL-15, but not IL-2 or
IL-21 in X-31 infected mice, whereas expression levels of IL-15ra
and IL-2rb were unaltered (data not shown).
Antigen presenting capacity of sorted IKDCs, B220
2NK
cells, and cDCs from infected lungs
After observing a clear increase in absolute number and
maturation state (MHCII and CD86) of IKDCs in lung tissue at 4
dpi, we decided to sort IKDCs from infected mice and perform a
head to head comparison with their two closest family members,
cDCs and B220
2 NK cells for the capacity to present to CD8 or
CD4 T cells. To study the antigen presenting capacity of the
different cell subsets we infected mice either with an influenza
virus containing the OVA MHCI (SIINFEKL) or MHCII
OVA323–339 epitope. At 4 dpi DC and NK cell subsets were
sorted with a purity exceeding 98% from the lung tissue and put in
co-culture with either CFSE-labeled OVA specific CD8
+ T cells
(OT-1) or CD4
+ T cells (OT-2), taken from the respective TCR
transgenic animals. As a negative control, co-cultures were set up
with influenza virus infected cDCs in which the opposite OVA
epitope was expressed (for example: a virus containing the MHCII
OVA epitope for presentation to OT-1 cells). To test if any lung
cell exposed to the innate cytokine response would be able to
induce proliferation of OT-1 T cells, additional cocultures were set
up with CD45
2 lung epitelial cells as APCs. Four days later, CFSE
dilution of T cells was measured by flowcytometry, and expressed
as the % of cells that had divided at least once. As shown in
Figure 4A, cDCs induced strong CD4 T cell proliferation ex vivo
following influenza infection (48% recruited into cell division),
whereas IKDCs only induced the proliferation in 3% and
B220
2NK cells in 5% of co-cultured CD4 T cells. In the
supernatant of the co-culture we determined levels of IL-2 and
IFN-c (Figure 4B) and according to the T cell division we found
high levels of IL-2 in the co-culture with cDCs. High levels of IFN-
c were induced in the co-culture with cDC and B220
2 NK cells
but not with IKDCs. Next, we studied the capacity to induce CD8
T cell proliferation (Figure 4C). Conventional DCs induced the
proliferation of up to 95% of co-cultured CD8
+ Ag specific T cells.
In contrast to the lack of induction of CD4 responses, IKDCs
presented influenza derived OVA epitopes to CD8
+ T cells (53%
Figure 2. IKDCs and B220
2 NK cells induce cell lysis. (A) Expression of Granzyme A and B on sorted cell subsets at 4 dpi. Bars represent the
values of expression relative to NTC. (B) Percentage YAC-1 cell target lysis after co-culture with different effector DC and NK cell subsets. IKDCs, B220
2
NK cells and DCs were sorted from lung tissue at 4 dpi following gating strategies depicted in Figure 1 and compared with enriched NK cells from
spleen tissue. Cells were incubated with CFSE-labeled NK-sensitive YAC-1 target cells. Lysis at each effector:target (E:T) ratio was determined as
described in materials and methods. Representative of 2 experiments.
doi:10.1371/journal.pone.0007187.g002
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PLoS ONE | www.plosone.org 4 September 2009 | Volume 4 | Issue 9 | e7187Figure 3. Kinetics of increase in IKDCs, B220
2NK cells, and cDCs in lung tissue after influenza virus infection. (A) Cell populations were
gated as demonstrated in Figure 1. Histograms demonstrate absolute numbers of IKDCs, B220
2NK cells and cDCs at different time points after
infection. Bars represent mean values +/2 SEM of at least 5 mice per group. CD86 (B) and MHCII (C) expression on cell populations at 4 dpi expressed
as mean MFI +/2 SEM, derived from at least five mice per group. Similar results were obtained from three separate experiments (D) Gene expression
analysis using Aff ymetrix GeneChips. Top heat map shows NK related chemokines and growth factors. Lower map shows NK related gene products.
doi:10.1371/journal.pone.0007187.g003
IKDC in Influenza
PLoS ONE | www.plosone.org 5 September 2009 | Volume 4 | Issue 9 | e7187Figure 4. Antigen-presenting capacity of lung cDCs and NK cell subsets. Lung populations were sorted following the gating strategies in
Figure 1. (A) CFSE-labelled OT-2 (CD4
+) – T cell proliferation 4 days after co-culture with cDCs, IKDCs and B220
2 NK cells sorted from lung tissue of
mice infected with PR-8 containing the OVA-CD4
+ epitope. Negative control sample indicates co-culture of OTII cells with cDCs derived from a mouse
infected with a MHCI-OVA epitope containing virus. Histogram represents average % of cells divided, from 3 seperately performed experiments.
Lower left plots indicate T cell proliferation after addition of OT-2 peptide to the co-cultures. (B) Histogram represent IL-2 and IFN-c levels in
supernatant of OTII co-cultures (C) Panel shows the same data for CFSE-labelled OT-1 (CD8
+) - T cell proliferation 4 days after co-culture with cDCs,
IKDCs, B220
2 NK cells and CD45-negative epithelial cells sorted from lung tissue of mice infected with WSN containing the OVA-CD8
+ epitope.
Negative controls in this setting are co-culture of OTI cells with cDCs derived from a mouse infected with a MHCII-OVA epitope containing virus.
Numbers in top left corners of all plots represent the percentage of cells recruited into cell division and the histogram shows average % cell divisions
of 3 separate experiments. (D) Histograms represent IL-2 and IFN-c levels in supernatant of OTI co-cultures with different ratios of DCs versus OTI T
cells. (E) Expression of TAP-1, Sec61a1, Cathepsin S and invariant chain on sorted cell subsets at 4 dpi. Bars represent the values of expression relative
to NTC. (D) Percentage of cells that have nucleoprotein (NP) positivity, measured by flowcytometry, and indicating replicative infection. Bars
represent an average of at least 5 mice/group +/2 SEM.
doi:10.1371/journal.pone.0007187.g004
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B220
2NK cells (62% recuited into cell division). Lung epithelial
cells did not induce any T cell divisions. Cytokine profiles in
Figure 4D supported these data; high levels of both IL-2 and IFN-
c were measured in the cDC co-culture, whereas similar (yet
lower) levels were found in cultures with IKDCs and NK cells, and
epithelial cells failed to induce IL-2 or IFN-c. The cytokine
production in supernatant showed a clear dose dependency in all
APC populations, which were put into co-culture with several
concentrations of OT-1 T cells. These data correlated with intra-
cellular staining of IFN-c (data not shown) The absence of CD4 T
cell response induction in the face of clear CD8 activation could
signify a defect in processing of viral antigen for MHCII pathway
or an absence of co-stimulatory molecules on NK subsets. To
address the maximum amount of proliferation possible in co-
cultures of purified lung APCs and purified T cells, we added pre-
processed MHCII-restricted OVA323–332 peptide to the co-culture
of IKDCs and OT-II cells, which induced efficient proliferation in
up to 50% of CD4 cells, similar to the degree of division seen in T
cells stimulated with cDCs (67%). Likewise, addition of MHCI-
restricted OVA peptide led to identical T cell proliferation
induced by IKDCs and cDCs. It has been proposed that
specializations of DCs to either cross-present to CD8 cells or to
CD4 cells is a function of particular DC subsets caused by the
expression of specific enzymes involved in antigen processing in
particular DC subsets, or differential expression of antigen-uptake
receptors [28,29]. To study antigen-processing capacity of the
various isolated NK-like cell populations, quantitative PCRs were
performed on the sorted cell subsets (Figure 4E). Class II
processing and loading molecules (cathepsin S and invariant
chain) were expressed in high levels by cDCs and to a much lesser
extent in IKDCs or B220
2NK cells. MHCI pathway molecules
Sec61a1 (an endoplasmatic reticulum membrane protein translo-
cator involved in crosspresentation to CD8 T cells) and TAP-1
(ATP-binding cassette transporter associated with MHCI loading)
were expressed on cDCs and on both IKDC and B220
2NK cells.
Differences in APC capacity might also reflect different degrees by
which these cells were infected by influenza virus. To address this
point, we studied the degree of infection by staining for
nucleoprotein (NP) in the separate cell subsets at 4 dpi [13].
Whereas 15% of cDCs and B220
2 NK cell isolated from the lung
were infected, we found that only 5% of IKDCs were NP positive
(Figure 4F).
Depletion of NK1.1 positive cells during influenza virus
infection reduces the innate and adaptive immune
response to influenza
The described experiments suggested that IKDCs and B220
2
NK cells had APC potential for CD8 cells ex vivo. To study the role
of NK1.1
+ cells during infection in vivo we injected the NK1.1-
specific depleting antibody PK136 before and throughout
influenza infection or mock infection [30]. Both in mock infected
and infected mice, intra-peritoneal (i.p.) injection of the antibody
efficiently depleted NKG2D
+ B220
2NK cells and IKDCs from
the lung tissue (Figure 5A) when compared to injection with
isotype Ig diluted in PBS, although depletion was more absolute in
mock infected mice. On the contrast, cDC numbers were
unaffected by treatment with NK1.1. Previously an enhancing
effect of NK cells on the state of maturation and antigen-
presenting capacity of cDCs has been suggested [31,32,33]. To
exclude any confounding effects of NK1.1 depletion on cDC
functions, we additionally compared the antigen presenting
capacity of sorted cDCs after infection with influenza virus
containing the OVA MHCI epitope, in mice treated or not with
PK136. At 4 dpi cDCs were sorted from both groups and
expressed similar levels of co-stimulatory molecules (CD86) and
MHCII and induced the same amount of T cell proliferation
(Figure S1). We next addressed the impact of NK1.1 depletion on
induction of antiviral innate and adaptive immunity to a mild X-
31 pulmonary influenza infection. During the early innate
response to influenza, IFN-c is found in high levels at the site of
infection (lung tissue and BAL fluid) [13] and NK cells are the
most prominent source of this cytokine [6,11]. Not surprisingly, we
found a decrease of IFN-c at 4 dpi in mice depleted of NK1.1 cells.
At 8 dpi this mild influenza X-31 infection has been cleared from
the lungs and therefore IFN-c levels start decreasing at this time
point (Figure 5B). Viral titers in mice lacking NK1.1 cells were
increased 5 fold at 4 dpi compared with mice treated with isotype
control antibody. Nevertheless virus was efficiently cleared at 8 dpi
(Figure 5C). Most importantly, to address the contribution of
NK1.1 positive cells on induction of adaptive CTL immunity, we
measured the percentage of virus-specific CD8 T cells at day 8
post infection by using a PE labeled H-2D
b tetramer with the
NP366–374 epitope ASNENMETM [13]. At day 8 we found
decreased numbers of tetramer (TM) positive cells in both spleen
and lung tissue (Figure 5D). In addition to this we determined the
hemagluttinin specific antibodies in serum at 8 dpi (Figure 5E) and
found increased levels following NK1.1 depletion, supporting the
higher viral titers. Both at earlier and later time points, similar
conclusions on tetramer positive cell induction and humoral
immune responses were reached (Figure S2). Surprisingly, NK1.1
depleted mice did not appear to have much more severe systemic
morbidity as their weight loss did not exceed 10% of initial weight,
in contrast with isotype treated mice, which lost significantly more
weight during the peak of infection (Figure 5F). As a final support
for an antigen presenting capacity of NK cells in vivo, we also found
colocalization of naı ¨ve OVA-specific CD8 T cells with NK cells
in the draining nodes 48 h after infection with influenza-OVA
virus but to a much lower extent with wild type influenza virus
(Figure S3).
Discussion
NK cells are part of the innate immune system and among the
first immune effector cells to arrive at inflammation sites [5,11].
Here, we found rapid accumulation of cells with an IKDC
phenotype in infected lungs. The reason for this could be
enhanced recruitment of IKDCs to the lungs, or enhanced
proliferation and/or survival of IKDCs in the infected lung.
Although little is known about chemokines and their receptors that
govern directed migration of IKDCs, CCR2 and CXCR3 are
likely candidates based on a recent study [27] and similarities with
NK cell migration [34]. Accordingly, we found an early yet
persistent upregulation of the ligands CXCL10 and CXCL11 as
well as CCR2 and CCL2 in virus-infected lungs. We also found
increased expression of IL-15 in the lungs, a critical cytokine
involved in IKDC development, expansion and survival in steady
state [16,21,23] and inflammatory conditions [27].
Another likely explanation for the increased number of NK-like
cells in the lungs following infection could be that cells are
interconverting by differentiation, thereby upregulating markers
on their surface. We do not exclude that IKDCs could be a highly
differentiated NK cell but decided to study both NK cell subsets
separately and compare them with cDCs in lung tissue.
Although the predominant effector function of NK cells is the
direct attack of virus-infected cells, as illustrated here by an
increase in early viral titer in the lungs of NK1.1 depleted mice,
increasing evidence suggests that they shape the quality and
IKDC in Influenza
PLoS ONE | www.plosone.org 7 September 2009 | Volume 4 | Issue 9 | e7187Figure 5. Depletion of NK1.1
+ cells during in vivo influenza virus infection affects infection parameters. (A) 2 days after injection of
PK136 (NK1.1 depleting antibody), mice were infected with X31 virus. Two days later, depletion of NK subsets and cDCs was checked in lung tissue by
using the gating strategy in Figure 1. (B) IFN-c was measured in BALf of infected mice versus mock-infected mice with or without NK1.1
+ cell
depletion. Bars represent mean values of IFN-c +/2 SEM. At least 5 mice per group were used, * p,0,05. (C) Viral titers were measured in lung tissue
of at least 5 mice per group and expressed as mean TCID50 +/2 SEM. * p,0,05. (D) Absolute numbers of TM specific CD8
+ T cells were measured in
spleen and lung tissue at 8 dpi and represented as mean values +/2 SEM, of at least 5 mice/group. (E) Hemagluttinin specific antibodies in serum
were measured at 8 dpi and depicted as geometric mean titer +/2 SE. * p,0,05. (F) Weight loss of mice during infection depicted as % of initial
weight. Values indicate mean of at least 5 mice per group +/2 SEM.*p,0,05. The demonstrated data are representative of 4 independently
performed experiments.
doi:10.1371/journal.pone.0007187.g005
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PLoS ONE | www.plosone.org 8 September 2009 | Volume 4 | Issue 9 | e7187quantity of the ensuing adaptive immune response by either
stimulating or suppressing the function of bona fide APCs like DCs
[31,32,33,34,35,36]. NK cells have extensive trafficking capabil-
ities and are found within non-lymphoid and lymphoid tissues,
sometimes in close proximity to naı ¨ve T cells, as also shown in this
study [34,37]. In vitro studies revealed that activated human NK
cells and NK cell clones can process soluble antigen, up-regulate
MHCII and co-stimulatory molecules, and thus stimulate naı ¨ve
CD4 and CD8 T cell responses [19,20]. The functional relevance
of this has been questioned in vivo, as mouse NK cells were
classically not found to have direct APC function [17,18].
Recently, it was proposed that IKDCs found in central lymphoid
organs and tumours are the in vivo mouse correlates of human NK
cells that display DC-like properties, such as expression of CD86,
MHCII and potential to present pre-processed peptides to T cells
[14,15,17]. Although in the original description, these cells were
proposed to be a separate and new subset of NK-like DCs,
subsequently three different groups refuted this idea and proposed
that IKDCs are nothing else but DC-like NK cells [16,21,23].
Regardless of these ‘family affairs’ between NK cells and DCs,
the argument that NK cells might be endowed with APC potential
made us embark on a detailed study in the mouse in which we
evaluated the precise contribution of NK cells to induction of
adaptive immunity during influenza infection of the lung. We
repeated an experiment previously reported by Kos and Engleman
in which depletion of NK1.1
+ cells was shown to hamper the
induction of virus-specific CD8 CTLs [30]. This experiment had
been performed in an era when it was impossible to identify virus-
specific CD8 T cells with MHCI-peptide tetramers and multi-
colour flow cytometry was not so advanced as to discriminate and
sort multiple subsets of NK cells and DCs simultaneously. In our
hands, injection of an NK1.1 depleting antibody effectively
depleted the NKG2D
+ conventional B220
2NK cells, as well as
IKDCs, which led to a reduction of tetramer-positive NP366–374-
specific CD8 T cells upon viral infection, as measured at several
time points post infection. Although our data on reduced CTL
frequency support the early work of Kos et al, the interpretation
has been that NK cells promote the accessory function of DCs via
secretion of IFN-c or direct cell-cell contact [30,31]. However
several other explanations are plausible. By studying the
expression of MHCII, CD86 and the potential of cDCs to present
viral derived antigen to CD8 T cells, we found little evidence for
altered DC accessory function when NK1.1-positive cells were
depleted during influenza, lending little support to the former
theory. Alternatively, NK1.1 Ab treatment might have eliminated
CD8 CTLs directly, as NK1.1 is expressed by some 10% of virus
specific CD8 CTLs ([38] and our own unpublished data). We do
not believe that direct killing of CTLs by NK1.1 antibody was
responsible for the observed effect because as many as 50% of
tetramer-positive CD8 cells were depleted. CD3-positive NK T
cells also express the NK1.1 marker, yet these cells were recently
shown not to play a predominant role for antiviral immunity
during influenza infection [39]. Our data on the antigen
presenting capacities of NK cell subsets ex vivo, as well as the
colocalization of NK cells and naı ¨ve CD8 T cells in the central
lymphoid organs at early time points post infection favour the
theory that CD8 T cell responses were partially reduced because
of the depletion of B220
2NK cells and IKDCs, as direct actors in
the process of antigen presentation to naive antigen-specific CD8
T cells.
As recently suggested by others, we also found that during
influenza infection the APC functions of NK cells are present within
as u b s e to fl u n gC D 3
2CD19
2NK1.1
+ B220
+CD11c
+ cells that also
express killing activity for classical NK targets [14,15]. However, this
APC feature was not unique to IKDCs and similarly present in
B220
2 conventional NK cells. Both subsets upregulated the
expression of CD86 upon influenza infection and presented to
CD8 T cells. This could be a reflection of direct Ag presentation in
case of direct infection of NK subsets by influenza virus or cross-
presentation of virally infected lung epithelial cells. At least for
IKDCs we favour the latter explanation as we did not find real
evidence of direct infection of IKDCs by influenza (low levels of viral
nucleoprotein staining compared with cDCs [13,21]), and as IKDCs
highly expressed members of the ER retro translocation machinery
Sec61a1 (involved in cross-presentation) and cathepsin S, also
recently implicated to play a role in crosspriming [28,29]. How
exactly IKDCs acquire antigen for cross-presentation however is
unclearatpresentaswedidnotaddresstheircapacitytophagocytose
virusinfectedcells,northecausalrelationshipbetween killingof virus
infected cells and subsequent processing of antigen derived from
killedtarget cells.The division that wasinduced exvivo in CD8 T cells
by IKDCs was not accompanied by vigorous IFN-c production, in
contrast to T cells stimulated with cDCs under identical conditions.
One factor that discriminates lung NK cell subsets is the higher
level of expression of MHCII on IKDCs compared with B220
2
NK cells in infected lung samples. It was therefore striking to see
that IKDCs hardly presented influenza derived antigen to specific
CD4 T cells, whereas cDCs readily did under these conditions.
The most obvious explanation would be the much higher level of
co-stimulatory molecules and MHC molecules on cDCs, and
expression of the full enzymatic machinery to process antigen for
the MHCII pathway in cDCs. Supporting this idea, we did find
that addition of pre-processed MHCII peptide on IKDCs led to T
cell divisions, albeit at reduced vigour compared with similarly
pulsed cDCs. The apparent lack of mRNA expression of invariant
chain by B220
2NK cells and IKDCs, compared with cDCs
explains the incapacity to process for MHCII, as invariant chain is
crucial for proper intracellular routing and loading of MHCII
molecules by endosomal cargo [28,29,40]. Strikingly, the coculture
of B220
2 NK cells and naı ¨ve CD4 T cells, did lead to a good
production of IFN-c. The fact that this was not accompanied by
CD4 T cell division, makes it likely that this IFN-c response was
NK-derived. The idea that IKDCs have MHC processing capacity
has been questioned by other studies showing a very weak
potential of these cells to present antigen to CD4 T cells ex vivo
following expansion in Gleevec/IL-2 and maturation by IL-15
[27], or following exposure in vitro to soluble protein antigens or
pathogens [21]. It is possible that IL-15 present in the lungs of
influenza infected mice (as detected from our whole lung mRNA
array data) shuts down part of the APC function of IKDCs for
CD4 T cells, as recently demonstrated in vitro [27].
At first sight our data on the APC capabilities of IKDCs are at
odds with recent papers studying this subject. In vitro work in the
human immune system illustrated how activated NK cells
expressing MHCII and co-stimulatory molecules could process
influenza hemaglutinin (HA) protein and virus infected targets for
presentation to HA-specific CD8
+ and CD4
+ T cell clones [20].
There could be major differences between in vitro activated human
NK cells and ex vivo lung derived murine NK cells that have been
part of an innate immune response to live influenza infection. In
one of the papers refuting the idea that IKDCs represent a subset
of DCs it was shown that splenic IKDCs were unable to present
viral antigens to influenza specific T cells following in vitro
influenza infection, even after CpG stimulation [21]. This could
reflect the need for a cell population or cytokine response in vivo
that licences NK cell subsets to become APCs at the site of
infection. Clearly, finding such a stimulus could be very instructive
in finding ways to improve mucosal vaccines.
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infecting the lung tissue seriously affects the phenotypical
appearance of cells, which makes multi-color flowcytometry
necessary to distinguish multiple cell subsets. We found in vivo
and ex vivo evidence for antigen presenting capacities within
IKDCs and conventional NK cells during influenza infection. All
together, clearance of influenza virus from the lungs is therefore
yet another example of the delicate crosstalk between innate and
adaptive immune response that emerged through evolution to
safeguard the host from infectious threats while avoiding immune
pathology to the host.
Materials and Methods
Influenza virus infection
C57BL/6 mice (6–8 weeks) were purchased from Harlan (Zeist,
The Netherlands). Influenza virus X-31 (MRC, Cambridge,
England) was inoculated in the allantoic cavity of embryonated
chicken eggs. Infectious virus titers were determined in Madin-
Darby Canine Kidney (MDCK) cells. Lungs were homogenized
and ten-fold serial dilutions of these samples were used in eight-
fold to determine the virus titers in MDCK cells as described
previously [41]. All experiments were approved by an independ-
ent animal ethics committee at Erasmus MC Rotterdam, the
Netherlands.
NK1.1 cell depletion
Naive C57BL/6 mice were treated i.p. with 200 mg of anti-
NK1.1 mAb (PK136) on day 22 followed by infection with
influenza X-31 at day 0. Subsequent i.p. injections of 100 mg anti-
NK1.1. were given at day 0, 1, 2, 3, 4, 5 and 7 post infection. As a
control mice were treated with isotype IgG from mouse serum
(Sigma-Aldrich).
Flow cytometry and cell sorting
For detection and phenotyping of DC subsets in organs, cell
suspensions of lung, MLN and spleen were prepared as described
previously[42]. Cells were subsequently stained with moAbs
directed against 120G8 FITC (kindly provided by C.Asselin-
Paturel), CD11b PE, MHCII PECy5, B220 PECy7, NKG2D
PECy7, CD122 Pacific Orange (eBioscience), CD11c PETxR
(Caltag), NK1.1 APC, CD3 APC Cy7, CD19 APC Cy7 (BD
Biosciences), and a live/dead marker (DAPI) in Violet. Acquisition
of 9–10 color samples was done on a LSRII cytometer. Cell
sorting was performed on a FacsARIA cytometer and after cell
sorting purity was checked and sorted cells were counted in a
Burker cytometer using Trypan Blue. For measurement or viral
nucleoprotein (NP) in cells FITC labeld anti-NP antibody
(DakoCytomation) was used. Virus-specific CTL were detected
by tetramer-staining with following antibodies: CD3e-PerCP,
CD8b.2-FITC (PharMingen, San Diego, United States), ToPro
3-APC (Molecular Probes,Eugene, United States) and PE labeled
H-2D
b tetramer with the NP366–374 epitope ASNENMETM
(Sanquin Research, Amsterdam, The Netherlands). Final analysis
and graphical output were performed using FlowJo software
(Treestar, Costa Mesa, CA).
Flow cytometry–based cytotoxicity assay
Effector cells from infected lungs were sorted on a FacsARIA
cytometer and as a positive control spleen NK cells (isolated from
infected spleens of the same mice of which lungs had been
obtained) were enriched by MACS cell sorting with DX-5
antibodies according to manufacturer’s protocol (Miltenyi Biotec
GmbH). All effector cells were labeled with CFSE [43] and plated
in serial dilution. Target cells (YAC-1) were harvested in
exponential growth phase, washed and plated 2000 target
cells/well. As a positive control 2% triton was added to a
number of wells containing only YAC-1 cells. Cells were
centrifuged for 1 minute at 335 g to facilitate cell-cell contact,
and incubated for 4 hours at 37uC. At the end of the incubation
time samples were put in an ice water bath and Micro Beads were
added to allow a constant number of measuring on the LSRII
Flowcytometer (BD Bioscience, USA). Prior to measuring, DAPI
was added for labeling of dead cells. All samples were analysed
using FlowJo software (Treestar, Costa Mesa, CA) as described
previously [26].
Antigen presentation assays
For antigen presentation assays of lung DC subsets, mice were
infected with WSN influenza virus encoding OVA257–264 K
b
restricted MHC I epitope in the neuraminidase [44] and PR-8
influenza virus encoding OVA323–339 MHC II epitope in
hemagglutinin of the virus [45]. The OVA viruses were kindly
provided by Dr. R.Webby (St. Jude Children’s Hospital,
Memphis, Tennessee, USA). OT-1 and OT-2 transgenic T cells
were isolated from spleens and LN of respective mice, enriched by
MACS cell sorting with anti-CD8 or –CD4 antibodies according
to manufacturer’s protocol (Miltenyi Biotec GmbH) and labeled
with CFSE[43]. Sorted DC subsets were counted and alive cells
were co-cultured with T cells at 1/10 ratio for 4 days. T cell
divisions were measured by flow cytometry and supernatants were
collected and stored at 220uC until ELISA for IFN-c and IL-2
(BD Biosciences) was performed in 96 wells ELISA plates (Greiner
Bio-One).
Affymetrix GeneChip hybridization and analysis
Mice were infected with 10
5 influenza virus X-31 at day 0. At
several time points after infection (6, 24, 48, 96, 192 hours) mice
were sacrificed, lungs were collected in RNAeasy and stored at
280uC. Total lung RNA from influenza virus infected lungs was
isolated using an RNeasy kit (Qiagen). RNA was biotin labeled
and hybridized to mouse micro arrays (Affymetrix Mouse 430.2).
Real-time quantitative RT–PCR
Quantative RT-PCR for TAP-1, Sec61a1, Cathepsin S,
invariant chain, Granzym A and Granzym B were performed
on RNA from sorted DC subsets and NK cells. Frozen cell pellets
were homogenized, RNA was isolated with RNAqueous micro kit
(Ambion) and treated with DNaseI, according to the manufactur-
er’s protocol. RNA (100 ng) was reverse transcribed using
SuperscriptII (Invitrogen) and random hexamers (Amersham
Biosciences) for 50 min at 42uC. Quantitative PCR was performed
with Taqman Universal PCR Mastermix (Applied Biosystems) and
preformulated primers and probe mixes (‘Assay on Demand’,
Applied Biosystems). PCR conditions were 2 min at 50uC, 10 min
at 95uC, followed by 40 cycles of 15 s at 95uC and 60uC for 1 min
using an ABI PRISM 7300 (Applied Biosystems). PCR amplifi-
cation of the housekeeping gene encoding ubiquitin C was
performed during each run for each sample to allow normalization
between samples.
Statistical analysis
All experiments were performed using 5–10 animals per group.
The difference between groups was calculated using the Mann-
Whitney U test for unpaired data (GraphPad Prism version 4.0;
GraphPad, San Diego, CA). Differences were considered signif-
icant when p,0,05.
IKDC in Influenza
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Figure S1 Effect of NK1.1 depletion of APC capacities of lung
cDCs. (A) Expression of CD86 on cDCs taken at 4dpi from the
lungs of influenza infected mice, that were treated with depleting
NK1.1 antibody or isotype control. (B) Antigen presenting
capacity of cDCs sorted from lung tissue at 4 days after infection
with WSN containing an OVA-CD8+ epitope. Sorted cells were
co-cultured for 4 days with CFSE-labelled OVA specific CD8 T
cells (OT1). A comparison was made between cDCs sorted from
NK depleted mice (NK1.1-) versus non-depleted mice, which
received an isotype control injection (PBS). Numbers in top left
corners represent the percentage of cells recruited into cell
division.
Found at: doi:10.1371/journal.pone.0007187.s001 (4.77 MB TIF)
Figure S2 Depletion of NK1.1+ cells during in vivo influenza
virus infection affects infection parameters at various time points
following infection. Mice were treated with depleting NK1.1
antibody or isotype control during influenza virus infection. (A)
Viral titers were measured in lung tissue at day 5, 7, and 13 post
infection. (B) Left plot shows TM specific CD8+ T cells measured
in MLN at day 5, 7, and 13 pos infection. Right plot demonstrates
IFNc producing CD8+ T cells in MLN, measured by intra-cellular
staining. (C) % of CD4 T cells in MLN following infection. (D)
Hemagluttinin specific antibodies in serum were measured at 8 dpi
and depicted as geometric mean titer6SE. In all experiments at
least 5 mice per group were used and values are expressed as
mean6SEM. * p,0,05.
Found at: doi:10.1371/journal.pone.0007187.s002 (18.94 MB
TIF)
Figure S3 Colocalization of NK cells and naı ¨ve CD8 T cells in
MLN at early time points post infection. Adoptive transfer of naı ¨ve
Ly5.2 OTI CD8+ cells (reactive to OVA class I epitope) was
performed to Ly5.1 recipients, allowing to detect OVA specific
CD8 T cells using a Ly5.2 antibody. 1 day later mice were
immunized with influenza virus containing the OVA class I
epitope (Flu (OVA insert)) or with wild type influenza virus (Flu).
At 2 days post infection MLN were stained for NK cells with an
antibody against NK1.1. (blue) and Ly5.2 T cells (red).We could
observe several NK cells in close proximity to naı ¨ve CD8 T cells,
but only in mice infected with the virus containing the OVA
epitope.
Found at: doi:10.1371/journal.pone.0007187.s003 (4.23 MB TIF)
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